- ￥2300
- 齐源
- 151202
- 国产/进口
- 2025年07月10日
- IHC-F, ICC
- 大鼠
- 人、小鼠
6 年钻石会员
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
齐源
- 库存：
999
- 靶点：
Ki-67
- 级别：
mouse/human Ki-67 Antibody
- 目录编号：
mouse/human Ki-67 Antibody
- 克隆性：
单克隆
- 抗原来源：
大鼠
- 保质期：
mouse/human Ki-67 Antibody
- 抗体英文名：
Purified anti-mouse/human Ki-67 Antibody
- 抗体名：
mouse/human Ki-67 Antibody
- 标记物：
mouse/human Ki-67 Antibody
- 宿主：
大鼠
- 适应物种：
人、小鼠
- 免疫原：
mouse/human Ki-67 Antibody
- 亚型：
mouse/human Ki-67 Antibody
- 形态：
mouse/human Ki-67 Antibody
- 应用范围：
IHC-F, ICC
- 保存条件：
2-8℃
- 浓度：
0.5 mg/ml
- 规格：
100 µg
Purified anti-mouse/human Ki-67 Antibody详细如下：
Description ：The nuclear protein Ki-67 was first identified by the monoclonal antibody Ki-67, which wasgenerated by immunizing mice with nuclei of the L428 Hodgkin lymphoma cell line. Ki-67 proteinplays an essential role in ribosomal RNA transcription and cell proliferation. Expression of Ki-67occurs during G1, S, G2, and M phase. While in G0 phase, the Ki-67 protein is not detectable.Ki-67 is strongly expressed in proliferating cells and has been reported as a prognostic markerin various tumors.
Verified Reactivity ：Mouse, Human
Antibody Type ：Monoclonal
Host Species ：Rat
Immunogen ：E. coli expressed, N-terminal His-Thioredoxin-tagged, partial mKi-67 (1816-2163 aa) recombinantprotein.
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation ：The antibody was purified by affinity chromatography.
Concentration ：0.5 mg/ml
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C.
Application ：IHC-F - Quality tested、ICC - Verified
Recommended Usage ：Each lot of this antibody is quality control tested by immunocytochemistry. Forimmunocytochemistry, a concentration range of 1.25 - 5.0 μg/ml is recommended. Forimmunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 1.25 -5.0 µg per ml. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Description ：The nuclear protein Ki-67 was first identified by the monoclonal antibody Ki-67, which wasgenerated by immunizing mice with nuclei of the L428 Hodgkin lymphoma cell line. Ki-67 proteinplays an essential role in ribosomal RNA transcription and cell proliferation. Expression of Ki-67occurs during G1, S, G2, and M phase. While in G0 phase, the Ki-67 protein is not detectable.Ki-67 is strongly expressed in proliferating cells and has been reported as a prognostic markerin various tumors.
Verified Reactivity ：Mouse, Human
Antibody Type ：Monoclonal
Host Species ：Rat
Immunogen ：E. coli expressed, N-terminal His-Thioredoxin-tagged, partial mKi-67 (1816-2163 aa) recombinantprotein.
Formulation ：Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation ：The antibody was purified by affinity chromatography.
Concentration ：0.5 mg/ml
Storage & Handling ：The antibody solution should be stored undiluted between 2°C and 8°C.
Application ：IHC-F - Quality tested、ICC - Verified
Recommended Usage ：Each lot of this antibody is quality control tested by immunocytochemistry. Forimmunocytochemistry, a concentration range of 1.25 - 5.0 μg/ml is recommended. Forimmunohistochemical staining on frozen tissue sections, the suggested use of this reagent is 1.25 -5.0 µg per ml. It is recommended that the reagent be titrated for optimal performance for eachapplication.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Product Citations：
1. Su T, et al. 2021. Metabolites. 11:. PubMed
2. Miyauchi K, et al. 2021. Front Immunol. 12:663177. PubMed
3. Flores–Santibáñez F, et al. 2018. Front Immunol. 0.520138889. PubMed
4. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
5. Schrage R, et al. 2015. Nat Commun. 6: 10156. PubMed
6. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
7. Reyes RV, et al. 2022. Front Neurosci. 16:908719. PubMed
8. Coover RA, et al. 2018. Acta Neuropathol Commun. 6:127. PubMed
9. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
10. Lee YS, et al. 2018. Cell Host Microbe. 24:833. PubMed
11. Ren J, et al. 2018. Cell Cycle. 1.25. PubMed
1. Su T, et al. 2021. Metabolites. 11:. PubMed
2. Miyauchi K, et al. 2021. Front Immunol. 12:663177. PubMed
3. Flores–Santibáñez F, et al. 2018. Front Immunol. 0.520138889. PubMed
4. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
5. Schrage R, et al. 2015. Nat Commun. 6: 10156. PubMed
6. Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
7. Reyes RV, et al. 2022. Front Neurosci. 16:908719. PubMed
8. Coover RA, et al. 2018. Acta Neuropathol Commun. 6:127. PubMed
9. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
10. Lee YS, et al. 2018. Cell Host Microbe. 24:833. PubMed
11. Ren J, et al. 2018. Cell Cycle. 1.25. PubMed
文献支持
Purified 抗小鼠/人 Ki-67 抗体
￥2300
